Scientists probe Gut's role in boosting cancer treatment
NCT ID NCT07236983
Summary
This study aims to understand how the variety of bacteria in a person's gut (the gut microbiome) might influence how well they respond to cancer immunotherapy and whether it affects side effects. Researchers will observe 70 adults with solid tumors who are starting immunotherapy. They will collect stool and blood samples and track diet and body composition to look for connections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR CANCER TREATMENT WITH IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Oncologia
Pavia, Pavia, 27100, Italy
Conditions
Explore the condition pages connected to this study.